Hu et al. reported that when bevacizumab was administered alone in glioblastoma xenografts HIF-1α-dependent BNIP3 levels increased and autophagy was activated, promoting tumor growth; this adaptive response could be prevented by an autophagy inhibitor such as chloroquine [77]. The gene discussed is HIF1A; the disease is neoplasm.